Literature DB >> 27470455

High-Output Heart Failure: A 15-Year Experience.

Yogesh N V Reddy1, Vojtech Melenovsky1, Margaret M Redfield1, Rick A Nishimura1, Barry A Borlaug2.   

Abstract

BACKGROUND: High-output heart failure (HF) is an unusual cause of cardiac failure that has not been well-characterized.
OBJECTIVES: This study sought to characterize the etiologies, pathophysiology, clinical and hemodynamic characteristics, and outcomes of high-output HF in the modern era.
METHODS: We performed a retrospective analysis of all consecutive patients referred to the Mayo Clinic catheterization laboratory for hemodynamic assessment between 2000 and 2014. Subjects with definite HF, as defined by the Framingham criteria, were compared to controls of similar age and sex.
RESULTS: The most common etiologies of high-output HF (n = 120) were obesity (31%), liver disease (23%), arteriovenous shunts (23%), lung disease (16%), and myeloproliferative disorders (8%). Compared with controls (n = 24), subjects with high-output HF displayed eccentric left ventricular remodeling, greater natriuretic peptide activation, higher filling pressures, pulmonary hypertension, and increased cardiac output, despite similar ejection fraction. Elevated cardiac output in high-output HF patients was related to both lower arterial afterload (decreased systemic vascular resistance) and higher metabolic rate. Mortality was increased in high-output HF as compared with controls (hazard ratio: 3.4; 95% confidence interval: 1.6 to 7.6). Hemodynamics and outcomes were poorest amongst patients with the lowest systemic vascular resistance.
CONCLUSIONS: High-output HF is an important cause of clinical HF in the modern era that is related to excessive vasodilation, and most frequently caused by obesity, arteriovenous shunts, and liver disease. Given the high mortality and increasing prevalence of these comorbidities in Western countries, high-output HF must be considered in the differential diagnosis of patients presenting with dyspnea, congestion, and a normal ejection fraction.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cirrhosis; hemodynamics; obesity

Mesh:

Year:  2016        PMID: 27470455     DOI: 10.1016/j.jacc.2016.05.043

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  60 in total

1.  Can Oxygen Transport Analysis Tell Us Why People With Heart Failure With Preserved Ejection Fraction Feel So Poorly?

Authors:  Barry A Borlaug
Journal:  Circulation       Date:  2018-01-09       Impact factor: 29.690

2.  Adverse Renal Response to Decongestion in the Obese Phenotype of Heart Failure With Preserved Ejection Fraction.

Authors:  Yogesh N V Reddy; Masaru Obokata; Jeffrey M Testani; G Michael Felker; W H Wilson Tang; Omar F Abou-Ezzeddine; Jie-Lena Sun; Hrishikesh Chakrabothy; Steven McNulty; Sanjiv J Shah; Gregory D Lewis; Lynne W Stevenson; Margaret M Redfield; Barry A Borlaug
Journal:  J Card Fail       Date:  2019-10-13       Impact factor: 5.712

3.  Is it time to recognize a new phenotype? Heart failure with preserved ejection fraction with pulmonary vascular disease.

Authors:  Barry A Borlaug; Masaru Obokata
Journal:  Eur Heart J       Date:  2017-10-07       Impact factor: 29.983

Review 4.  Treatment Barriers in Portopulmonary Hypertension.

Authors:  Batool AbuHalimeh; Michael J Krowka; Adriano R Tonelli
Journal:  Hepatology       Date:  2018-12-18       Impact factor: 17.425

5.  Redefining Cirrhotic Cardiomyopathy for the Modern Era.

Authors:  Manhal Izzy; Lisa B VanWagner; Grace Lin; Mario Altieri; James Y Findlay; Jae K Oh; Kymberly D Watt; Samuel S Lee
Journal:  Hepatology       Date:  2019-10-11       Impact factor: 17.425

Review 6.  Medical Management of Pulmonary Hypertension with Unclear and/or Multifactorial Mechanisms (Group 5): Is There a Role for Pulmonary Arterial Hypertension Medications?

Authors:  Jason Weatherald; Laurent Savale; Marc Humbert
Journal:  Curr Hypertens Rep       Date:  2017-10-18       Impact factor: 5.369

7.  Relationships of high cardiac output with ventricular morphology, myocardial energetics, and energy costs in hemodialysis patients with preserved ejection fraction.

Authors:  Tomonari Harada; Masaru Obokata; Koji Kurosawa; Hidemi Sorimachi; Kuniko Yoshida; Hideki Ishida; Kyoko Ito; Tetsuya Ogawa; Yoshitaka Ando; Masahiko Kurabayashi; Kazuaki Negishi
Journal:  Int J Cardiovasc Imaging       Date:  2018-10-16       Impact factor: 2.357

8.  Letter by Reddy et al Regarding Article, "Effects of Arteriovenous Fistula Ligation on Cardiac Structure and Function in Kidney Transplant Recipients".

Authors:  Yogesh N V Reddy; Karl A Nath; Barry A Borlaug
Journal:  Circulation       Date:  2019-11-18       Impact factor: 29.690

9.  An Unusual, Reversible Cause of Acute High-Output Heart Failure Complicated by Refractory Shock.

Authors:  Matthew S Durstenfeld; Priscilla Y Hsue
Journal:  Circulation       Date:  2020-08-31       Impact factor: 29.690

10.  Hemodynamics of Fontan Failure: The Role of Pulmonary Vascular Disease.

Authors:  Alexander C Egbe; Heidi M Connolly; William R Miranda; Naser M Ammash; Donald J Hagler; Gruschen R Veldtman; Barry A Borlaug
Journal:  Circ Heart Fail       Date:  2017-12       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.